15th August 2019

 

MICAP, providers of quality independent due diligence and research into the tax-advantaged investment market, have released the latest EIS Reviews of the Deepbridge Technology Growth EIS and Deepbridge Life Sciences EIS.

You may access both of the documents below:

Deepbridge Technology Growth EIS: MICAP Review

Deepbridge Life Sciences EIS: MICAP Review

Please note, registration may be required in order to access these reports.

 

Should you you wish to further discuss any of our investment propositions, please contact the Deepbridge team, here.